Lianhua Qingwen tea is fake.
Recently, Yiling Pharmaceutical, a manufacturer of Lianhua Qingwen, issued an official statement in WeChat official account, saying that many commodities named Lianhua Qingwen Tea, Lianhua Qingwen Tea, Lianhua Qingwen Ointment, Lianhua Qingwen Oral Liquid, Lianhua Qingwen Plant Beverage and Lianhua Qingwen Pill appeared in the market recently, and none of the above commodities were produced, sold or authorized by our company.
It is mentioned in the statement that "Lian Hua Qing Wen" and "Lian Hua Qing" are trademarks registered by our company according to law and obtained the exclusive right to use trademarks; The design patent of Lianhua Qingwen Capsule produced by our company is not authorized to be used by others; Our company reserves the right to investigate the relevant legal responsibilities of the responsible person for producing and selling counterfeit products, confusing our products and other acts that infringe our legitimate rights and interests such as the exclusive right to use trademarks.
Lianhua Qingwen
National Medical Products Administration once approved Lianhua Qingwen Capsule (granule) to add a new indication for treating "novel coronavirus mild and common type" on the basis of the original approved indication, with a course of 7 to 1 days. Lianhua Qingwen Capsule (granule) recommended in this edition can be used for the prevention and treatment of light and common types in medical observation period and clinical treatment period.
This is the sixth time that Lianhua Qingwen has been recommended by the national plan to treat COVID-19 since the outbreak. Counting down, Lianhua Qingwen has entered the market since 23, from influenza A, influenza B, avian influenza to new coronavirus pneumonia, among the major public health incidents of virus infectivity that occurred in China in the past ten years. Even Huaqing pestilence has been recommended by the treatment plan.